Reports
Reports
Sale
The global ureteroscopy market is expected to grow at a CAGR of 5.1% during the forecast period of 2024-2032, driven by increasing prevalence of urinary tract stones and rising preference for minimally invasive surgeries across the globe.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Ureteroscopy devices refer to a range of specialized instruments and equipment used in ureteroscopy procedures, which are minimally invasive endoscopic procedures for diagnosing and treating conditions within the urinary tract, particularly the ureter and kidney. These devices are designed to facilitate visualization, access, and intervention within the urinary tract during ureteroscopic procedures.
The factors driving the growth of the ureteroscopy market include technological advancements in endoscopic equipment, growing demand for minimally invasive procedures, expanding applications of ureteroscopy, and improvements in healthcare infrastructure and reimbursement policies. Further, the rising burden of urinary tract stones is a significant driver of this market. The integration of telemedicine and remote monitoring technologies into urological practice is impacting the delivery of ureteroscopy services. Remote monitoring of patients undergoing ureteroscopy procedures enables real-time assessment of outcomes and early detection of complications, enhancing patient safety and continuity of care, which is expected to increase the market demand.
Increasing Prevalence of Urinary Tract Stones
The rising incidence and prevalence of urinary tract stones, including kidney stones and ureteral stones, are significant drivers of the ureteroscopy market. Factors such as changes in dietary habits, sedentary lifestyles, and demographic shifts contribute to the growing number of patients requiring treatment for urinary stones. According to NIH, kidney stones are becoming increasingly common in the global population. About 11% of men and 6% of women in the United States have kidney stones at least once during their lifetime.
As the prevalence of urinary tract stones rises, there is a corresponding increase in the demand for treatment options. Urinary stones can cause significant discomfort, pain, and complications such as urinary tract infections and kidney damage. Patients seek medical intervention to alleviate symptoms and address the underlying condition, driving the demand for effective treatment which leads to increase in market growth.
Rising Technological Innovations Expected to Fuel Ureteroscopy Market Demand
The technological innovations in ureteroscopic devices and accessories enhance the efficiency, safety, and effectiveness of ureteroscopy procedures. The advancements include improvements in optics, miniaturization of instruments, development of digital ureteroscopes, and enhancements in stone fragmentation technologies. These technological advancements drive adoption by improving visualization, maneuverability, and stone management outcomes. In April 2024, Olympus announced that it has received U.S. FDA 510(k) clearance of its first single use ureteroscope system, RenaFlex. The RenaFlex single-use flexible ureteroscope system is used to visualize and access the urinary tract to diagnose and treat urinary diseases and disorders. The RenaFlex system is intended to visualize organs, cavities, and canals in the urinary tract (urethra, bladder, ureter, calyces and renal papillae) via transurethral or percutaneous access routes.
Hence, the rising technological advancement is expected to augment the market demand.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:
Trends | Impact |
Rising Preference for Minimally Invasive Procedures | There is a growing preference for minimally invasive procedures like ureteroscopy over traditional open surgeries. The minimally invasive techniques offer benefits such as shorter recovery times, reduced hospital stays, and decreased post-operative pain. This trend is driving increased adoption of ureteroscopy for the management of urinary tract conditions, particularly urinary stones. |
Shift Towards Disposable Ureteroscopes | There is a growing trend towards the adoption of disposable ureteroscopes. Disposable ureteroscopes offer advantages such as reduced risk of cross-contamination, elimination of reprocessing costs, and convenience in outpatient settings. Healthcare facilities are increasingly incorporating disposable ureteroscopes into their practices, contributing to market growth. |
Rise in Strategic Partnerships | The ureteroscopy market is influenced by strategic mergers and acquisitions activities among manufacturers, healthcare providers, and technology companies that are driving innovation and fostering market expansion. These collaborations are accelerating the development of advanced products and augmenting the market reach globally. |
Expanding Indications | Ureteroscopy is being increasingly used for a broader range of indications beyond stone management. These include the diagnosis and treatment of ureteral strictures, urothelial tumors, and other urinary tract abnormalities. The expanding indications for ureteroscopy are driving market growth and opening up new opportunities for manufacturers and healthcare providers. |
Market Breakup by Type
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
Market Segmentation Based on Type is Anticipated to Witness Substantial Growth
By type, the market is segmented into flexible ureteroscopes, semi-rigid ureteroscopes and rigid ureteroscopes. The ureteroscopes come in various types, each designed to meet specific clinical needs and preferences. The flexible ureteroscope segment is dominating the market as they are designed to navigate through the tortuous anatomy of the urinary tract with exceptional precision. The articulating tip and flexible shaft enable urologists to reach target areas within the ureter and kidney, allowing for thorough inspection and precise intervention. Hence, it contributes to a major market share.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on the region, the market report covers North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is dominating the market share due to high prevalence of urinary tract stones, companies in the region continuously invest in research and development to develop advanced ureteroscopic technologies, such as digital imaging systems, flexible ureteroscopes, and integrated visualization platforms. Moreover, sophisticated healthcare infrastructure and industry collaborations are some of the key factors leads to growth in the market.
Europe also holds a high ureteroscopy market value driven by increasing technological advancements Additionally, Asia Pacific is expected to witness substantial market growth fueled by the growing patient pool suffering from stone disease and increasing government initiatives. The rising demand for minimally invasive surgeries is also boosting the region’s market share.
The key features of the market report include funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Storz Medical AG
Storz Medical AG is a Swiss-based medical device company known for its innovative technologies and products in various medical specialties, including urology. The company offers a range of urological instruments and devices, including ureteroscopes. Storz Medical AG's ureteroscopes are designed to provide high-quality visualization and precise navigation for diagnostic and therapeutic procedures within the urinary tract, particularly the ureter and kidney.
Boston Scientific Corporation
Boston Scientific Corporation offers a range of innovative products and solutions in various urological medical devices. The company is well-known for its comprehensive portfolio of urological devices, including urinary stone management and endourology products. The company is engaged in supplying single use flexible ureteroscope.
Stryker
Stryker Corporation is a leading global medical technology company is known for its innovative products and solutions across multiple medical specialties, including urology, orthopedics, neurology, spine, and surgical instruments. The company is engaged in offering semi-rigid ureteroscope.
Olympus Corporation
Olympus Corporation is a renowned global manufacturer of optical and digital precision technology for healthcare, life sciences, and consumer electronics. Among its extensive range of medical devices, Olympus is known for its expertise in endoscopy equipment, including ureteroscopes.
Other key players in the market include Elmed Medical Systems, Rocamed, Cook Medical, OTU Medical Inc., and Accel Medical among others.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Type |
|
Breakup by Application |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Ureteroscopy Market Overview
3.1 Global Ureteroscopy Market Historical Value (2017-2023)
3.2 Global Ureteroscopy Market Forecast Value (2024-2032)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Ureteroscopy Market Landscape*
5.1 Global Ureteroscopy: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Ureteroscopy: Product Landscape
5.2.1 Analysis by Type
6 Global Ureteroscopy Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter’s Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Ureteroscopy Market, Epidemiology Snapshot
7.1 Overview of Global Ureteroscopy Incidence Number (2017-2032)
7.2 Incidence Number, By Indication (2017-2032)
7.2.1 Kidney Cancer
7.2.2 Urolithiasis
7.2.3 Urinary Stricture
7.2.4 Others
8 Global Ureteroscopy Market Segmentation (2017-2032)
8.1 Global Ureteroscopy Market (2017-2032) by Type
8.1.1 Market Overview
8.1.2 Flexible Ureteroscopes
8.1.3 Semi-rigid Ureteroscopes
8.1.4 Rigid Ureteroscopes
8.2 Global Ureteroscopy Market (2017-2032) by Application
8.2.1 Market Overview
8.2.2 Kidney Cancer
8.2.3 Urolithiasis
8.2.4 Urinary Stricture
8.2.5 Others
8.3 Global Ureteroscopy Market (2017-2032) by End User
8.3.1 Market Overview
8.3.2 Hospitals
8.3.3 Specialty Clinics
8.3.4 Ambulatory Surgery Centers
8.3.5 Others
8.4 Global Ureteroscopy Market (2017-2032) by Region
8.4.1 Market Overview
8.4.2 North America
8.4.3 Europe
8.4.4 Asia Pacific
8.4.5 Latin America
8.4.6 Middle East and Africa
9 North America Ureteroscopy Market (2017-2032)
9.1 North America Ureteroscopy Market (2017-2032) by Type
9.1.1 Market Overview
9.1.2 Flexible Ureteroscopes
9.1.3 Semi-rigid Ureteroscopes
9.1.4 Rigid Ureteroscopes
9.2 North America Ureteroscopy Market (2017-2032) by Application
9.2.1 Market Overview
9.2.2 Kidney Cancer
9.2.3 Urolithiasis
9.2.4 Urinary Stricture
9.2.5 Others
9.3 North America Ureteroscopy Market (2017-2032) by End User
9.3.1 Market Overview
9.3.2 Hospitals
9.3.3 Specialty Clinics
9.3.4 Ambulatory Surgery Centers
9.3.5 Others
9.4 North America Ureteroscopy Market (2017-2032) by Country
9.4.1 United States of America
9.4.2 Canada
10 Europe Ureteroscopy Market (2017-2032)
10.1 Europe Ureteroscopy Market (2017-2032) by Type
10.1.1 Market Overview
10.1.2 Flexible Ureteroscopes
10.1.3 Semi-rigid Ureteroscopes
10.1.4 Rigid Ureteroscopes
10.2 Europe Ureteroscopy Market (2017-2032) by Application
10.2.1 Market Overview
10.2.2 Kidney Cancer
10.2.3 Urolithiasis
10.2.4 Urinary Stricture
10.2.5 Others
10.3 Europe Ureteroscopy Market (2017-2032) by End User
10.3.1 Market Overview
10.3.2 Hospitals
10.3.3 Specialty Clinics
10.3.4 Ambulatory Surgery Centers
10.3.5 Others
10.4 Europe Ureteroscopy Market (2017-2032) by Country
10.4.1 United Kingdom
10.4.2 Germany
10.4.3 France
10.4.4 Italy
10.4.5 Others
11 Asia Pacific Ureteroscopy Market (2017-2032)
11.1 Asia Pacific Ureteroscopy Market (2017-2032) by Type
11.1.1 Market Overview
11.1.2 Flexible Ureteroscopes
11.1.3 Semi-rigid Ureteroscopes
11.1.4 Rigid Ureteroscopes
11.2 Asia Pacific Ureteroscopy Market (2017-2032) by Application
11.2.1 Market Overview
11.2.2 Kidney Cancer
11.2.3 Urolithiasis
11.2.4 Urinary Stricture
11.2.5 Others
11.3 Asia Pacific Ureteroscopy Market (2017-2032) by End User
11.3.1 Market Overview
11.3.2 Hospitals
11.3.3 Specialty Clinics
11.3.4 Ambulatory Surgery Centers
11.3.5 Others
11.4 Asia Pacific Ureteroscopy Market (2017-2032) by Country
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 ASEAN
11.4.5 Australia
11.4.6 Others
12 Latin America Ureteroscopy Market (2017-2032)
12.1 Latin America Ureteroscopy Market (2017-2032) by Type
12.1.1 Market Overview
12.1.2 Flexible Ureteroscopes
12.1.3 Semi-rigid Ureteroscopes
12.1.4 Rigid Ureteroscopes
12.2 Latin America Ureteroscopy Market (2017-2032) by Application
12.2.1 Market Overview
12.2.2 Kidney Cancer
12.2.3 Urolithiasis
12.2.4 Urinary Stricture
12.2.5 Others
12.3 Latin America Ureteroscopy Market (2017-2032) by End User
12.3.1 Market Overview
12.3.2 Hospitals
12.3.3 Specialty Clinics
12.3.4 Ambulatory Surgery Centers
12.3.5 Others
12.4 Latin America Ureteroscopy Market (2017-2032) by Country
12.4.1 Brazil
12.4.2 Argentina
12.4.3 Mexico
12.4.4 Others
13 Middle East and Africa Ureteroscopy Market (2017-2032)
13.1 Middle East and Africa Ureteroscopy Market (2017-2032) by Type
13.1.1 Market Overview
13.1.2 Flexible Ureteroscopes
13.1.3 Semi-rigid Ureteroscopes
13.1.4 Rigid Ureteroscopes
13.2 Middle East and Africa Ureteroscopy Market (2017-2032) by Application
13.2.1 Market Overview
13.2.2 Kidney Cancer
13.2.3 Urolithiasis
13.2.4 Urinary Stricture
13.2.5 Others
13.3 Middle East and Africa Ureteroscopy Market (2017-2032) by End User
13.3.1 Market Overview
13.3.2 Hospitals
13.3.3 Specialty Clinics
13.3.4 Ambulatory Surgery Centers
13.3.5 Others
13.4 Middle East and Africa Ureteroscopy Market (2017-2032) by Country
13.4.1 Saudi Arabia
13.4.2 United Arab Emirates
13.4.3 Nigeria
13.4.4 South Africa
13.4.5 Others
14 Regulatory Framework
14.1 Regulatory Overview
14.2 US FDA
14.3 EU EMA
14.4 INDIA CDSCO
14.5 JAPAN PMDA
14.6 Others
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Strategic Initiatives
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership and Collaborations
16.3 Analysis by Joint Ventures
16.4 Analysis by Leading Players
16.5 Analysis by Geography
17 Supplier Landscape
17.1 Market Share Analysis, By Region (Top 5 Companies)
17.1.1 Market Share Analysis: Global
17.1.2 Market Share Analysis: North America
17.1.3 Market Share Analysis: Europe
17.1.4 Market Share Analysis: Asia-Pacific
17.1.5 Market Share Analysis: Others
17.2 Storz Medical AG
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Boston Scientific Corporation
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Elmed Medical Systems
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Rocamed
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Olympus Corporation
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 OTU Medical Inc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Cook Medical
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Accel Medical
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Stryker
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
18 Global Ureteroscopy Market – Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
**The supplier list is not exhaustive. Moreover, we can provide analysis of companies as per custom requests.
Datasheet
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.